Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future

Published:2014-12-31 Issue:3 Volume:61 Page:326-337
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Cantarini Luca,Rigante Donato,Vitale Antonio,Napodano Salvatore,Sakkas Lazaros I.,Bogdanos Dimitrios P.,Shoenfeld Yehuda

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-014-8615-z.pdf

Reference97 articles.

1. Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev. 2013;12:340–54.

2. Sakkas LI, Chikanza IC, Platsoucas CD. Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2:679–85.

3. Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48:1956–63.

4. Grossman C, Dovrish Z, Shoenfeld Y, Amital H. Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev. 2011;10:244–7.

5. Randone SB, Guiducci S, Matucci-Cerinic M. Systemic sclerosis and infections. Autoimmun Rev. 2008;8:36–40.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review;Seminars in Arthritis and Rheumatism;2024-10

2. Efficacy and safety of intravenous immunoglobulin therapy in systemic sclerosis: a systematic review;Rheumatology International;2024-05-15

3. Atteinte sévère de l’intestin grêle et pseudo-obstruction intestinale chronique au cours de la sclérodermie systémique : bases physiopathologiques, diagnostiques et thérapeutiques, dont la nutrition parentérale;La Revue de Médecine Interne;2024-03

4. Immune-Targeted Therapies in SSc;Scleroderma;2024

5. Recent Advances in Treatment of Systemic Sclerosis and Morphea;American Journal of Clinical Dermatology;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3